Genpact (NYSE:G – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Saturday.
A number of other equities analysts have also recently weighed in on G. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Genpact in a report on Wednesday, October 8th. Needham & Company LLC increased their target price on Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a research report on Friday, August 8th. Citigroup raised shares of Genpact to a “hold” rating in a report on Thursday, October 23rd. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a research report on Wednesday, August 20th. Three analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $51.13.
Check Out Our Latest Research Report on Genpact
Genpact Price Performance
Genpact (NYSE:G – Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The business services provider reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.07. The firm had revenue of $1.29 billion for the quarter, compared to the consensus estimate of $1.27 billion. Genpact had a net margin of 11.01% and a return on equity of 22.55%. The firm’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.85 earnings per share. Genpact has set its FY 2025 guidance at 3.600-3.610 EPS. Q4 2025 guidance at 0.930-0.940 EPS. Analysts expect that Genpact will post 3.21 EPS for the current year.
Insider Transactions at Genpact
In other news, Director Tamara Franklin sold 2,750 shares of Genpact stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $45.65, for a total transaction of $125,537.50. Following the completion of the transaction, the director owned 22,236 shares of the company’s stock, valued at $1,015,073.40. The trade was a 11.01% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, SVP Piyush Mehta sold 76,902 shares of the stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the completion of the sale, the senior vice president directly owned 134,880 shares in the company, valued at approximately $5,743,190.40. The trade was a 36.31% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 161,183 shares of company stock worth $6,970,760. Corporate insiders own 3.07% of the company’s stock.
Institutional Trading of Genpact
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Creative Planning raised its holdings in Genpact by 53.9% in the 3rd quarter. Creative Planning now owns 59,440 shares of the business services provider’s stock valued at $2,490,000 after acquiring an additional 20,820 shares during the last quarter. Lazard Asset Management LLC grew its position in shares of Genpact by 295.8% in the third quarter. Lazard Asset Management LLC now owns 358,595 shares of the business services provider’s stock valued at $15,022,000 after purchasing an additional 268,001 shares during the period. AQR Capital Management LLC increased its stake in Genpact by 170.4% in the third quarter. AQR Capital Management LLC now owns 3,443,472 shares of the business services provider’s stock valued at $144,247,000 after purchasing an additional 2,170,145 shares during the last quarter. Credit Agricole S A acquired a new position in Genpact in the third quarter valued at $1,532,000. Finally, Raymond James Financial Inc. boosted its stake in Genpact by 26.7% in the 3rd quarter. Raymond James Financial Inc. now owns 204,104 shares of the business services provider’s stock worth $8,550,000 after buying an additional 43,009 shares during the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Stories
- Five stocks we like better than Genpact
- Investing In Automotive Stocks
- Are These 3 Oversold Tech Giants Ready to Rebound?
- How to Calculate Options Profits
- If You Wait for the Dip, Micron Technology Could Leave You Behind
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 3 Stocks Quietly Powering the AI and Tech Revolution
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
